Novavax (NVAX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $7.93 -1.73%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $8.03 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
